Cells (Jun 2023)

Specific Proteomic Identification of Collagen-Binding Proteins in <i>Escherichia coli</i> O157:H7: Characterisation of OmpA as a Potent Vaccine Antigen

  • Ricardo Monteiro,
  • Ingrid Chafsey,
  • Nelly Caccia,
  • Valentin Ageorges,
  • Sabine Leroy,
  • Didier Viala,
  • Michel Hébraud,
  • Valérie Livrelli,
  • Mariagrazia Pizza,
  • Alfredo Pezzicoli,
  • Mickaël Desvaux

DOI
https://doi.org/10.3390/cells12121634
Journal volume & issue
Vol. 12, no. 12
p. 1634

Abstract

Read online

Escherichia coli is a versatile commensal species of the animal gut that can also be a pathogen able to cause intestinal and extraintestinal infections. The plasticity of its genome has led to the evolution of pathogenic strains, which represent a threat to global health. Additionally, E. coli strains are major drivers of antibiotic resistance, highlighting the urgent need for new treatment and prevention measures. The antigenic and structural heterogeneity of enterohaemorrhagic E. coli colonisation factors has limited their use for the development of effective and cross-protective vaccines. However, the emergence of new strains that express virulence factors deriving from different E. coli diarrhoeagenic pathotypes suggests that a vaccine targeting conserved proteins could be a more effective approach. In this study, we conducted proteomics analysis and functional protein characterisation to identify a group of proteins potentially involved in the adhesion of E. coli O157:H7 to the extracellular matrix and intestinal epithelial cells. Among them, OmpA has been identified as a highly conserved and immunogenic antigen, playing a significant role in the adhesion phenotype of E. coli O157:H7 and in bacterial aggregation. Furthermore, antibodies raised against recombinant OmpA effectively reduced the adhesion of E. coli O157:H7 to intestinal epithelial cells. The present work highlights the role of OmpA as a potent antigen for the development of a vaccine against intestinal pathogenic E. coli.

Keywords